A multicenter trial of antithymocyte globulin in aplastic anemia and related diseases.

One hundred fifty patients with bone marrow failure were treated in three groups with antithymocyte globulin (ATG; Upjohn, Kalamazoo, MI) in a multicenter trial. Patients were assessed at 3, 6, and 12 months after initiation of treatment by three criteria: transfusion independence, clinical improvement, and blood counts. Group I consisted of 77 patients with acute severe aplastic anemia, randomized to receive either ten or 28 days of ATG. There was no significant difference between the two arms of this protocol: 47% of all patients were clinically improved and 31% were transfusion independent at 3 months. Of the severely affected patients, 27% died before 3 months; most deaths occurred early in treatment. Factors associated with survival in severely affected patients included male sex, age less than 40 years, absolute neutrophil count greater than 200/microL, and idiopathic etiology. Neutrophil counts generally increased by 8 weeks after treatment, but patients continued to show improvement to 1 year posttreatment. In Group II, 44 patients with moderate or chronic severe aplastic anemia were randomized to receive either ten days of ATG or 3 months of high-dose nandrolone decanoate. No patient initially treated with androgens recovered, but 28% of ATG-treated cases achieved transfusion independence at 3 months. Group III consisted of patients with a variety of bone marrow failure syndromes. Patients with pancytopenia and cellular bone marrow showed response rates similar to those of patients with chronic or moderate aplastic anemia.

[1]  J. Kaltwasser,et al.  Use of androgens in aplastic anemia. , 1990, The American journal of pediatric hematology/oncology.

[2]  F. Firkin,et al.  Antithymocyte globulin therapy for pure white cell aplasia , 1987, American journal of hematology.

[3]  F. Gardner,et al.  Androstane therapy to treat aplastic anaemia in adults: an uncontrolled pilot study , 1987, British journal of haematology.

[4]  H. Deeg,et al.  Treatment of aplastic anemia with antithymocyte globulin, high-dose corticosteroids, and androgens. , 1987, Experimental hematology.

[5]  E. Gordon-Smith,et al.  Survival after antilymphocyte globulin therapy for aplastic anemia depends on disease severity. , 1987, Blood.

[6]  N. Young,et al.  Biological and immunological characterization of ATG and ALG , 1986 .

[7]  A. Gratwohl,et al.  Treatment of severe aplastic anemia. , 1981, Experimental hematology.

[8]  S. Feig,et al.  Do androgens enhance the response to antithymocyte globulin in patients with aplastic anemia? A prospective randomized trial , 1985 .

[9]  A. Huang,et al.  Predictive factors for response to anti-thymocyte globulin in acquired aplastic anemia. , 1985, The American journal of medicine.

[10]  B. Speck,et al.  Antithymocyte and antilymphocyte globulins: clinical trials and mechanism of action. , 1984, Progress in clinical and biological research.

[11]  F. Frassoni,et al.  Treatment of severe aplastic anemia with sequential immunosuppression. , 1983, Experimental hematology.

[12]  R. Storb,et al.  Antithoracic duct lymphocyte globulin therapy of severe aplastic anemia. , 1983, Blood.

[13]  R. Branda,et al.  Antithymocyte globulin treatment of severe aplastic anaemia , 1983, British journal of haematology.

[14]  R. Champlin,et al.  Antithymocyte globulin treatment in patients with aplastic anemia: a prospective randomized trial. , 1983, The New England journal of medicine.

[15]  G. Tricot,et al.  Anti-thymocyte globulin treatment for aplastic anemia. , 2009, Scandinavian journal of haematology.

[16]  A. Cosimi,et al.  Treatment of severe aplastic anemia with a prolonged course of anti-thymocyte globulin. , 1982, Transplantation proceedings.

[17]  E. Gluckman,et al.  Results of immunosuppression in 170 cases of severe aplastic anaemia , 1982, British journal of haematology.

[18]  R. Bukowski,et al.  Treatment of severe aplastic anemia with antithymocyte globulin. , 1982, Experimental hematology.

[19]  Y. Najean Long-term follow-up in patients with aplastic anemia: A study of 137 androgen-treated patients surviving more than two years , 1981 .

[20]  A. Gratwohl,et al.  Treatment of severe aplastic anaemia with antilymphocyte globulin or bone-marrow transplantation. , 1981, British medical journal.

[21]  R. Storb,et al.  A prospective study of androgens and bone marrow transplantation for treatment of severe aplastic anemia. , 1979, Blood.